Universitätsklinikum Düsseldorf

Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia (2024) Burmeister T, Ströh AS, Kehden B, Trautmann H, Meyer C, Marschalek R, Larghero P, et al. Journal article, Letter Prioritization and Resource Allocation in the Context of the COVID-19 Pandemic: Recommendations for Colorectal and Pancreatic Cancer in Germany (2024) Lugnier C, Sommerlatte S, Attenberger U, Beer AJ, Bentz M, Benz SR, Birkner T, et al. Journal article Schwangerschaft und Mutterschutz in der Kardiologie und in der Kinder- und Jugendkardiologie (2024) Güder G, Boer J, Busch S, Gaede L, Graf T, Herberg U, Kretschmer A, et al. Journal article A longitudinal analysis of health inequalities from adolescence to young adulthood and their underlying causes (2024) Reuter M, Diehl K, Richter M, Sundmacher L, Hövener C, Spallek J, Dragano N Journal article Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer (2024) Jahangir CA, Page DB, Broeckx G, Gonzalez CA, Burke C, Murphy C, Reis-Filho JS, et al. Journal article, Review article Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma – knowledge obtained from the CheckRad-CD8 trial (2024) Hecht M, Frey B, Gaipl U, Tianyu X, Eckstein M, Donaubauer AJ, Klautke G, et al. Journal article Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis (2024) Ghallab A, González D, Strängberg E, Hofmann U, Myllys M, Hassan R, Hobloss Z, et al. Journal article Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer (2024) Fasching P, Decker T, Hartkopf A, Nusch A, Heinrich BJ, Kurbacher C, Fuchs R, et al. Journal article Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL (2024) Stelljes M, Raffel S, Alakel N, Wäsch R, Kondakci M, Scholl S, Rank A, et al. Journal article No Association Between Phenylketonuria or Hyperphenylalaninemia and Type 1 Diabetes: Insights From the German DPV Registry. (2024) Meyhöfer S, Hammersen J, Schmid S, Khodaverdi S, Dafsari RS, Otfried-Schwab K, Papsch M, et al. Journal article, Letter